First Time Loading...

Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 877 JPY 0.57% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

6.1B
Operating Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
+1 325%
7 Years
-
10 Years
+36 340%
-1B
-77%
Investing Cash Flow
Growth Rates:
1 Year
+60%
3 Years
-18%
5 Years
-488%
7 Years
-2 060%
10 Years
-
2.3B
-77%
Financing Cash Flow
Growth Rates:
1 Year
-69%
3 Years
+524%
5 Years
-
7 Years
+242%
10 Years
+1 171 400%

Cash Flow Statement
Pharma Foods International Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: JPY
Oct-2007 Apr-2008 Oct-2008 Apr-2009 Oct-2009 Apr-2010 Jul-2010 Oct-2010 Jan-2011 Apr-2011 Jul-2011 Jan-2012 Jul-2012 Jan-2013 Jul-2013 Jan-2014 Jul-2014 Jan-2015 Jul-2015 Jan-2016 Jul-2016 Jan-2017 Jul-2017 Jan-2018 Jul-2018 Jan-2019 Jul-2019 Jan-2020 Jul-2020 Jan-2021 Jul-2021 Jan-2022 Jul-2022 Jan-2023 Jul-2023
Operating Cash Flow
Net Income
(26)
(138)
68
107
23
218
234
14
16
(59)
(42)
(91)
66
299
294
175
12
(266)
(184)
(331)
29
(39)
124
(227)
314
925
669
(632)
849
2 316
5 765
8 001
1 423
(1 675)
3 542
Depreciation & Amortization
3
(0)
(4)
(11)
(1)
(5)
5
39
47
35
33
29
25
24
25
25
25
25
30
36
43
46
76
99
89
89
92
111
152
170
181
339
520
538
546
Other Non-Cash Items
(2)
(18)
(2)
75
1
(95)
(92)
(38)
(31)
42
43
76
36
(1)
26
20
(31)
14
(179)
(238)
6
27
23
30
27
(8)
(103)
(109)
(64)
(7)
14
(132)
(171)
11
160
Cash Taxes Paid
(74)
(74)
1
1
0
(1)
0
3
4
4
4
3
5
7
24
24
4
(6)
(6)
4
3
2
8
19
32
65
92
114
119
189
224
2 207
3 028
1 274
1 068
Cash Interest Paid
(0)
(0)
(0)
(0)
(0)
(0)
(0)
1
1
0
0
0
1
1
1
1
1
0
0
2
4
5
6
5
5
6
7
7
8
10
11
0
29
52
48
Change in Working Capital
298
318
(237)
(214)
(23)
(26)
(54)
(59)
15
(7)
(52)
(87)
52
(117)
(328)
(266)
(223)
27
91
20
(113)
194
11
185
(0)
(52)
(567)
(586)
(1 483)
(1 352)
(23)
(3 245)
(7 838)
(3 452)
1 874
Cash from Operating Activities
273
N/A
162
-41%
(175)
N/A
(43)
+76%
1
N/A
92
+18 380%
94
+1%
(44)
N/A
47
N/A
11
-77%
(19)
N/A
(72)
-285%
179
N/A
204
+14%
17
-92%
(46)
N/A
(217)
-372%
(200)
+8%
(242)
-21%
(512)
-112%
(35)
+93%
227
N/A
234
+3%
88
-62%
430
+390%
955
+122%
91
-91%
(1 216)
N/A
(547)
+55%
1 127
N/A
5 937
+427%
4 963
-16%
(6 066)
N/A
(4 578)
+25%
6 122
N/A
Investing Cash Flow
Capital Expenditures
242
326
1
(8)
0
11
11
0
0
0
(4)
(5)
(2)
(7)
(9)
(14)
(13)
(30)
(40)
(31)
(71)
(59)
(46)
(50)
(51)
(120)
(281)
(811)
(913)
(346)
(173)
(314)
(472)
(410)
(405)
Other Items
(3)
266
(15)
(629)
14
274
275
(286)
(295)
(1)
(1)
31
(38)
421
556
(59)
(169)
(33)
228
231
24
(334)
(337)
(110)
(122)
(9)
(20)
66
52
(56)
(269)
(2 081)
(2 067)
(161)
(607)
Cash from Investing Activities
239
N/A
592
+147%
(14)
N/A
(637)
-4 385%
14
N/A
285
+1 994%
286
+0%
(287)
N/A
(295)
-3%
(1)
+100%
(5)
-422%
25
N/A
(40)
N/A
414
N/A
548
+32%
(73)
N/A
(182)
-148%
(63)
+65%
189
N/A
199
+6%
(47)
N/A
(393)
-738%
(382)
+3%
(160)
+58%
(172)
-8%
(128)
+25%
(301)
-135%
(745)
-148%
(861)
-16%
(402)
+53%
(442)
-10%
(2 395)
-442%
(2 539)
-6%
(571)
+78%
(1 012)
-77%
Financing Cash Flow
Net Issuance of Common Stock
(5)
(5)
0
0
0
0
0
0
0
0
0
0
0
0
1
0
900
903
22
0
0
0
0
0
0
1
2
2
3
8
8
(293)
(294)
(298)
(298)
Net Issuance of Debt
0
0
0
5
0
(11)
(19)
(38)
(46)
(32)
(20)
195
199
(1)
(1)
(1)
(201)
(201)
(1)
772
679
1 036
906
(458)
(183)
1 078
1 695
137
471
2 960
1 320
668
8 857
11 133
3 240
Cash Paid for Dividends
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(102)
(247)
(290)
(726)
(871)
(580)
(578)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
2
6
4
(2)
1
1
(101)
(102)
(2)
3
(0)
(8)
(13)
(13)
(12)
(21)
Cash from Financing Activities
(5)
N/A
(5)
N/A
0
N/A
5
N/A
0
N/A
(11)
N/A
(19)
-75%
(38)
-103%
(46)
-21%
(32)
+30%
(20)
+37%
195
N/A
199
+2%
(1)
N/A
0
N/A
0
N/A
699
+349 550%
711
+2%
30
-96%
793
+2 573%
685
-14%
1 039
+52%
904
-13%
(458)
N/A
(182)
+60%
977
N/A
1 594
+63%
138
-91%
376
+173%
2 720
+624%
1 030
-62%
(364)
N/A
7 679
N/A
10 243
+33%
2 343
-77%
Change in Cash
Effect of Foreign Exchange Rates
0
(1)
(2)
0
2
2
1
(1)
(3)
(0)
(5)
(12)
(8)
30
44
25
12
16
19
(3)
(10)
1
4
(2)
(2)
(2)
(1)
2
(2)
(2)
(14)
(20)
(22)
(17)
5
Net Change in Cash
507
N/A
748
+48%
(192)
N/A
(675)
-252%
16
N/A
368
+2 172%
362
-2%
(369)
N/A
(297)
+20%
(23)
+92%
(48)
-114%
137
N/A
330
+142%
648
+96%
608
-6%
(94)
N/A
312
N/A
464
+49%
(5)
N/A
477
N/A
593
+24%
874
+48%
760
-13%
(531)
N/A
73
N/A
1 802
+2 360%
1 382
-23%
(1 822)
N/A
(1 034)
+43%
3 444
N/A
6 511
+89%
2 185
-66%
(948)
N/A
5 077
N/A
7 458
+47%
Free Cash Flow
Free Cash Flow
515
N/A
488
-5%
(175)
N/A
(51)
+71%
1
N/A
104
+17 150%
105
+1%
(44)
N/A
47
N/A
11
-77%
(23)
N/A
(78)
-244%
177
N/A
198
+12%
8
-96%
(60)
N/A
(230)
-282%
(230)
N/A
(282)
-23%
(544)
-93%
(106)
+80%
169
N/A
188
+11%
38
-80%
379
+901%
835
+120%
(190)
N/A
(2 028)
-967%
(1 460)
+28%
782
N/A
5 764
+637%
4 649
-19%
(6 538)
N/A
(4 988)
+24%
5 717
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.